Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27	92	228	115	288	167
Market Cap Growth	-65.76%	-59.70%	97.92%	-59.89%	72.07%	44.02%
Enterprise Value	63	133	268	167	336	218
Last Close Price	0.60	2.11	5.35	2.77	7.05	4.29
Forward PE	6.68	17.58	23.26	17.87	22.03	16.19
PS Ratio	0.30	0.98	2.04	1.02	2.42	1.64
PB Ratio	1.90	1.45	3.13	1.60	3.45	2.18
P/FCF Ratio	3.61	-	18.66	-	4294.24	20.44
P/OCF Ratio	3.14	63.91	16.28	100.17	227.98	17.92
PEG Ratio	-	1.03	1.03	1.03	1.03	1.03
EV/Sales Ratio	0.72	1.42	2.39	1.48	2.83	2.14
EV/EBITDA Ratio	12.60	54.64	28.27	70.15	29.73	22.08
EV/EBIT Ratio	-	-	107.55	-	91.12	96.86
EV/FCF Ratio	8.45	-	21.92	-	5018.20	26.69
Debt / Equity Ratio	3.04	0.70	0.59	0.75	0.68	0.75
Debt / EBITDA Ratio	5.87	9.65	3.70	12.09	4.24	4.79
Debt / FCF Ratio	5.75	-	3.51	-	850.15	7.04
Asset Turnover	0.84	0.71	0.79	0.74	0.75	0.64
Inventory Turnover	1.58	1.64	1.79	1.89	2.06	1.99
Quick Ratio	0.35	0.35	0.77	0.91	1.17	1.24
Current Ratio	0.81	0.82	1.85	2.20	2.43	2.46
Return on Equity (ROE)	-135.62%	-18.19%	-4.70%	-12.23%	-0.36%	-9.86%
Return on Assets (ROA)	-0.82%	-2.23%	1.10%	-2.11%	1.45%	0.88%
Return on Invested Capital (ROIC)	-2.69%	-4.38%	2.14%	-4.08%	2.85%	1.70%
Return on Capital Employed (ROCE)	-5.80%	-6.60%	2.30%	-4.30%	2.70%	1.70%
Earnings Yield	-200.30%	-13.48%	-1.49%	-8.25%	-0.10%	-4.67%
FCF Yield	27.68%	-1.31%	5.36%	-0.38%	0.02%	4.89%
Buyback Yield / Dilution	-2.01%	-2.64%	-2.43%	-2.65%	-4.41%	-2.19%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q